Monographs / Cardiovascular Risk and Testosterone Supplementation
expert
Physician-Scientist; Medical Director, Healthy Male; Director of Andrology Services, Hudson Institute of Medical Research; Consultant Andrologist, Monash IVF Group
This article examines the evidence for the cardiovascular safety of testosterone replacement therapy in older men with non-specific symptoms and unexplained low testosterone levels.
Written by Prof Robert I McLachlan, FRACP, PhD, AM
Professor Robert McLachlan is a NHMRC Principal Research Fellow at the Hudson Institute of Medical Research is the Director of Andrology Australia and Deputy Director of Endocrinology at Monash Medical Centre. Rob specialises in the area of male reproductive medicine and has made significant contributions to research in endocrinology, infertility and andrology.
Paediatric Gynae Vulval Problems
Practical Guide to Tirzepatide
COVID Update
Pregnancy and Epilepsy
expert
Physician-Scientist; Medical Director, Healthy Male; Director of Andrology Services, Hudson Institute of Medical Research; Consultant Andrologist, Monash IVF Group
Yes, for a majority of junior doctors
Yes, for about half of junior doctors
Yes, for a minority of junior doctors
No, not that I have observed
Listen to expert interviews.
Click to open in a new tab
Browse the latest monographs from Healthed.
You have completed the Educational Activities component of this resource.
Select ‘Confirm & claim CPD‘ to confirm you have engaged with this resource in its entirety and claim your CPD.
You will be taken to explore further CPD learning available to you.